Skip to Main Content
Serving the UMN community since 1900

The Minnesota Daily



Serving the UMN community since 1900

The Minnesota Daily

Serving the UMN community since 1900

The Minnesota Daily

Ozempic (Semaglutide), an injectable pen, is a weekly injection that helps the pancreas produce more insulin by lowering blood sugar levels.

Ozempic: UMN researchers insert their expertise

by Emma Walytka
Published May 1, 2024
What was originally created as a drug to treat type 2 diabetes has gained recent media attention around being used solely as a weight loss drug.

Accessibility Toolbar